BackAstria Therapeutics Overview

Astria Therapeutics Net Income

Profitability analysis for ATXS.

Quarterly Net Income

-$31.64M
28.98% YoY

As of Sep 2025

Annual Net Income (TTM)

-$124.03M
23.98% YoY

Trailing 12 months ending Sep 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...